Eric Neumann has joined Aventis as global head of knowledge management for the company’s Drug Innovation and Approval division. Prior to joining Aventis, Neumann was VP of bioinformatics and knowledge research at Beyond Genomics. He is also the co-founder and scientific advisor for Genstruct, and has held positions at 3rd Millennium, NetGenics (now Lion Bioscience), and Bolt, Beranek & Newman (now part of Verizon).
Elbert Branscomb, the chief scientist for the Department of Energy’s Genome Program and founding director of the DOE’s Joint Genome Institute, has been tapped as the new associate director for Biology and Biotechnology Research at Lawrence Livermore National Laboratory. Branscomb replaces Bert Weinstein, who has served as acting associate director for the directorate since 2000. Branscomb will manage a portfolio of interdisciplinary research and technology development programs at LLNL, including research in genomics, proteomics, computational biology, structural biology, disease susceptibility and prevention, and microbial biology. He will supervise around 325 employees. Branscomb joined LLNL in 1964 as a theoretical physicist, and served as a senior biomedical scientist at the lab from 1969 to 1996 prior to taking the helm at JGI.
Clinical trials software firm Pharsight has appointed Cynthia Stephens as senior vice president and CFO. Stephens joined the company in October 2003 as interim CFO. Prior to joining Pharsight, Stephens served as vice president of finance at Rainmaker Systems, a provider of sales and marketing programs for service contracts.